| Stereochemistry | ABSOLUTE |
| Molecular Formula | C14H28O6 |
| Molecular Weight | 292.3685 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
InChI
InChIKey=HEGSGKPQLMEBJL-RKQHYHRCSA-N
InChI=1S/C14H28O6/c1-2-3-4-5-6-7-8-19-14-13(18)12(17)11(16)10(9-15)20-14/h10-18H,2-9H2,1H3/t10-,11-,12+,13-,14-/m1/s1
| Molecular Formula | C14H28O6 |
| Molecular Weight | 292.3685 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
CAPRYLYL GLUCOSIDE is a mild and non-denaturing detergent for the solubilization and reconsititution of membrane bound proteins. Treatment with 1.2% N-octylglucoside for 5 min completely inhibited HIV-1 infectivity. CAPRYLYL GLUCOSIDE being nontoxic and inexpensive agent in inhibiting Staphylococcus epidermidis and Pseudomonas aeruginosa adhesion to conventional and silicone-hydrogel contact lenses. CAPRYLYL GLUCOSIDE was tested for the treatment of pulmonary tuberculosis. It was shown, that surfactant is proficient in removing Mycobacterium tuberculosis shield. Thus, it may also enhance the effectiveness of antibiotics and the immune system's response in the treatment of pulmonary tuberculosis.
Originator
Approval Year
PubMed
Patents
Sample Use Guides
Mice: 25 ul of surfactant in 0.15M NaCl was administered utilizing a Penn-Century syringe and shaft. Two days in succession weekly for
three weeks and once in the fourth week.
Route of Administration:
Other